LC Bead
Total Payments
$47,880
Transactions
3
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $47,880 | 3 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $47,880 | 3 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Pilot Study of Pembrolizumab and Liver-Directed Therapy or Peptide Receptor Radionuclide Therapy for Patients with Well-Differentiated Neuroendocrine Tumors and Symptomatic and/or Progressive Metastases | BOSTON SCIENTIFIC CORPORATION | $47,880 | 0 |
Top Doctors Receiving Payments for LC Bead
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | San Francisco, CA | $47,880 | 3 |
Ad
Manufacturing Companies
- BOSTON SCIENTIFIC CORPORATION $47,880
Product Information
- Type Device
- Total Payments $47,880
- Total Doctors 0
- Transactions 3
About LC Bead
LC Bead is a device associated with $47,880 in payments to 0 healthcare providers, recorded across 3 transactions in the CMS Open Payments database. The primary manufacturer is BOSTON SCIENTIFIC CORPORATION.
Payment data is available from 2021 to 2021. In 2021, $47,880 was paid across 3 transactions to 0 doctors.
The most common payment nature for LC Bead is "Unspecified" ($47,880, 100.0% of total).
LC Bead is associated with 1 research study, including "A Pilot Study of Pembrolizumab and Liver-Directed Therapy or Peptide Receptor Radionuclide Therapy for Patients with Well-Differentiated Neuroendocrine Tumors and Symptomatic and/or Progressive Metastases" ($47,880).